Pendal Group LTD Moderna, Inc. Transaction History
Pendal Group LTD
- $12.2 Billion
- Q4 2022
A detailed history of Pendal Group LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Pendal Group LTD holds 1,408 shares of MRNA stock, worth $36,129. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,408
Previous 11,176
87.4%
Holding current value
$36,129
Previous $1.32 Million
80.94%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding MRNA
# of Institutions
850Shares Held
252MCall Options Held
23.7MPut Options Held
30.3M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.07 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$656 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$567 Million0.48% of portfolio
-
State Street Corp Boston, MA17.8MShares$456 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$228 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...